
Sign up to save your podcasts
Or


TECENTRIQ® (atezolizumab), in combination with carboplatin and etoposide, is a first-line treatment option for adult patients with extensive-stage small cell lung cancer. What does this treatment path look like in clinical practice? Dr. Tracey Evans is joined by medical oncologist Dr. Raja Mudad to walk us through an example patient case that gives us a better sense of key diagnostic factors, treatment approach, and patient management.
This program is intended for US Physicians.
M-US-00010814(v1.0)
By ReachMD4
11 ratings
TECENTRIQ® (atezolizumab), in combination with carboplatin and etoposide, is a first-line treatment option for adult patients with extensive-stage small cell lung cancer. What does this treatment path look like in clinical practice? Dr. Tracey Evans is joined by medical oncologist Dr. Raja Mudad to walk us through an example patient case that gives us a better sense of key diagnostic factors, treatment approach, and patient management.
This program is intended for US Physicians.
M-US-00010814(v1.0)

3 Listeners

3 Listeners

0 Listeners

6 Listeners

15 Listeners

18 Listeners

0 Listeners